Bioventus (BVS) director exercises RSUs and holds 148,892 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Bioventus Inc. director Guy P. Nohra reported equity compensation activity consisting of a new grant of restricted stock units and the vesting of a prior award. On June 3, 2026, he received 25,146 restricted stock units, each representing a contingent right to one share of Class A common stock. On June 2, 2026, 32,282 restricted stock units vested and were exercised into 32,282 shares of Class A common stock, leaving him with 148,892 shares held directly after the transactions. These filings reflect routine equity awards and vesting rather than open-market purchases or sales.

Insider Trade Summary

32,282 shares exercised/converted

Mixed 3 txns

Insider NOHRA GUY P

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	25,146	$0.00	--
Exercise	Restricted Stock Units	32,282	$0.00	--
Exercise	Class A Common Stock	32,282	$0.00	--

Holdings After Transaction: Restricted Stock Units — 25,146 shares (Direct, null); Class A Common Stock — 148,892 shares (Direct, null)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. The RSUs vested on June 2, 2026. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Key Figures

RSU grant: 25,146 units RSUs vested and exercised: 32,282 units/shares Shares held after transactions: 148,892 shares +2 more

5 metrics

RSU grant 25,146 units Restricted stock units granted on June 3, 2026

RSUs vested and exercised 32,282 units/shares RSUs vested and converted into Class A common stock on June 2, 2026

Shares held after transactions 148,892 shares Direct Class A common stock holdings following June 2, 2026 transaction

Derivative exercises 1 transaction, 32,282 shares Exercise or conversion of derivative security reported in Form 4

Total acquire-type transactions 3 transactions All reported transactions categorized as acquisitions in summary

Key Terms

Restricted Stock Units, Class A common stock, vested, Exercise or conversion of derivative security

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A common stock financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vested financial

"The RSUs vested on June 2, 2026."

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/04/2026 - 04:47 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NOHRA GUY P

(Last)

(First)

(Middle)

4721 EMPEROR BOULEVARD, SUITE 100

(Street)

DURHAM

NORTH CAROLINA

27703

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/02/2026		M		32,282	A	$0	148,892	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/02/2026		M			32,282	⁽²⁾	⁽²⁾	Class A Common Stock	32,282	$0	0	D
Restricted Stock Units	⁽¹⁾	06/03/2026		A		25,146		⁽³⁾	⁽³⁾	Class A Common Stock	25,146	$0	25,146	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSUs vested on June 2, 2026.

3. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Remarks:

	/s/ Anthony D'Adamio, Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Bioventus (BVS) director Guy P. Nohra report?

Guy P. Nohra reported a grant of 25,146 restricted stock units and the vesting of 32,282 restricted stock units into 32,282 Class A common shares. These are compensation-related equity awards, not open-market purchases or sales of Bioventus stock.

How many Bioventus (BVS) shares does Guy P. Nohra hold after these transactions?

Following the reported transactions, Guy P. Nohra directly holds 148,892 shares of Bioventus Class A common stock. This total reflects the 32,282 shares received upon vesting of restricted stock units, as disclosed in the Form 4 insider filing.

What restricted stock unit grant did Bioventus (BVS) make to director Guy P. Nohra?

Bioventus granted Guy P. Nohra 25,146 restricted stock units, each representing a contingent right to receive one share of Class A common stock. The units vest based on continued service on the company’s board, as described in the filing’s footnotes.

Did Guy P. Nohra buy or sell Bioventus (BVS) shares on the open market?

The transactions reported involve a grant of 25,146 restricted stock units and the vesting of 32,282 restricted stock units into common shares. The filing does not show any open-market purchases or sales; these are compensation and vesting-related equity movements.

When did Guy P. Nohra’s Bioventus (BVS) restricted stock units vest?

The filing states that 32,282 restricted stock units vested on June 2, 2026, converting into 32,282 shares of Class A common stock. Another grant of 25,146 restricted stock units will vest based on future service conditions on the board.